Affiliation:
1. Department of Dermatology, SUNY Downstate Medical Center, Brooklyn, NY.
Abstract
The discovery of propranolol for the treatment of infantile hemangioma in 2008 has revolutionized management of this condition. Hundreds of reports have corroborated the initial published findings that propranolol is a safe and efficacious therapeutic agent. Furthermore, it is well tolerated in infants and can markedly alter the natural history and potential disfigurement of these lesions. The goal of this review is to outline the salient features of infantile hemangioma and the optimal use of propranolol as a first-line treatment modality.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intestinal hemangioma presenting as recurrent hematochezia in a 6-week-old male;Journal of Pediatric Surgery Case Reports;2015-07
2. Propranolol☆;Reference Module in Biomedical Sciences;2015